Guidant Mini IV ICD Debut Coincides With Unrelated Ventak AV II/III Fix
This article was originally published in The Gray Sheet
Executive Summary
The U.S. market launch of Guidant's Ventak Mini IV automatic implantantable cardioverter defibrillator commenced immediately following FDA approval via premarket approval application supplement on Dec. 8.